Loading...

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

BACKGROUND: Pragmatic use of the anti-fibrotic medications pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF) in the United States (US) has not been studied and may be different from international settings due to structural differences between health care systems. This study examined...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Res
Main Authors: Holtze, Colin H., Freiheit, Elizabeth A., Limb, Susan L., Stauffer, John L., Raimundo, Karina, Pan, Wayne T., Flaherty, Kevin R., Kim, Hyun J.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011239/
https://ncbi.nlm.nih.gov/pubmed/32041621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-1315-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!